Back to Journals » Cancer Management and Research » Volume 12

Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date

Total article views   HTML views PDF downloads Totals
11,234 Dovepress* 6,974+ 1,197 8,171
PubMed Central* 4,260 653 4,913
Totals 11,234 1,850 13,084
*Since 17 August 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar